Long-acting pasireotide improves clinical signs and quality of life in Cushing’s disease: results from a phase III study - Concepedia

Concepedia

Publication | Closed Access

Long-acting pasireotide improves clinical signs and quality of life in Cushing’s disease: results from a phase III study

27

Citations

18

References

2020

Year

André Lacroix, Marcello D. Bronstein, Jochen Schopohl, Roberto Salvatori, Yu Li, Ariel Barkan, Noriyuki Suzaki, Libuse Tauchmanovà, C.-E. Ortmann, S. Ravichandran,

Journal of Endocrinological Investigation

Long-acting PasireotideClinical SignsPathologyDegenerative DiseasePituitary DiseaseEndocrinologyMedicinePhase Iii Study

References

	Year	Citations

Page 1

Page 1